Find information on Pseudomonas urinary tract infection diagnosis, including clinical documentation, medical coding (ICD-10-CM N39.0), and healthcare guidelines. Learn about Pseudomonas aeruginosa UTI symptoms, treatment, and laboratory testing for accurate diagnosis and optimal patient care. Explore resources for healthcare professionals on managing and documenting Pseudomonas UTIs in clinical settings.
Also known as
Urinary tract infection, site not specified
Infection of the urinary tract, location unspecified, can include Pseudomonas.
Pseudomonas (aeruginosa) (mallei) (pseudomallei)
Identifies Pseudomonas as the causative agent of the infection.
Other diseases of the urinary system
Encompasses various urinary system disorders, including infections.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the UTI uncomplicated?
Yes
Site specified?
No
Pyelonephritis present?
When to use each related code
| Description |
|---|
| Pseudomonas UTI |
| Escherichia coli UTI |
| Klebsiella UTI |
Coding Pseudomonas UTI without laterality or specific site (e.g., kidney, bladder) may lead to claim denials and inaccurate data. CDI should query for specificity.
Incorrectly coding urosepsis as uncomplicated UTI can underestimate severity. CDI must differentiate localized UTI from systemic infection for accurate coding and reimbursement.
Failing to capture antibiotic resistance (e.g., MDR, XDR) in Pseudomonas UTI impacts infection control, quality metrics, and appropriate reimbursement. CDI and lab communication are crucial.
Patient presents with symptoms suggestive of a Pseudomonas aeruginosa urinary tract infection (UTI), including dysuria, urinary frequency, urgency, and suprapubic pain. The patient reports no fever, chills, or flank pain, indicating a possible uncomplicated UTI. Urinalysis reveals pyuria, bacteriuria, and positive leukocyte esterase. Urine culture confirms the presence of Pseudomonas aeruginosa. Differential diagnosis includes other bacterial UTIs, such as Escherichia coli UTI, Klebsiella pneumoniae UTI, and Enterococcus UTI. Considering the patient's clinical presentation and laboratory findings, the diagnosis of Pseudomonas aeruginosa urinary tract infection is established. Treatment plan includes antibiotic therapy with ciprofloxacin, levofloxacin, or an appropriate antipseudomonal agent based on susceptibility testing. Patient education provided on medication adherence, hydration, and follow-up urine culture. ICD-10 code N39.0, Urinary tract infection, site not specified, is assigned. CPT codes for urinalysis, urine culture, and office visit are documented based on the specific services rendered. Monitoring for treatment response and potential complications, such as pyelonephritis or urosepsis, will be conducted. Patient instructed to return for follow-up evaluation and repeat urine culture to assess treatment efficacy.